On the other hand, the C3aR-antagonist SB290157 has reported off-target activities in vivo, causing neutropenia independent to C3aR, as well as having C3aR agonist activity in certain cell settings [62,63]. Here, C3AR1 is linked to Decreased total neutrophil count.